<div dir="ltr"><br><div class="gmail_extra"><br><div class="gmail_quote">On Sat, Mar 24, 2018 at 1:56 PM, Heather Morrison <span dir="ltr"><<a href="mailto:Heather.Morrison@uottawa.ca" target="_blank">Heather.Morrison@uottawa.ca</a>></span> wrote:<br><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex">
<div>
<div>This is a repeat of one argument I made last week to focus on one argument at a time.</div>
<div><br>
</div>
<div>Either public domain or CC-BY is consistent with, and facilitates, toll access, both by the original publisher and downstream.</div>
<div><br>
</div>
<div>To date the best examples I have seen of creative use of CC-BY for commercial profit-making are Elsevier's ability to incorporate such works into their toll access services such as Scopus and metadata sales, at no cost to Elsevier, and Springer's harvesting
of images from CC-BY works for TA image bank (few years ago).</div></div></blockquote><div><br></div><div>Assuming ths was the collection of images into "Springer Images" in 2012 this is not a correct record. I have documented this in considerable detail in my blog - there are many entries (e.g. <a href="https://blogs.ch.cam.ac.uk/pmr/2012/06/06/springergate-springerimages-for-today/">https://blogs.ch.cam.ac.uk/pmr/2012/06/06/springergate-springerimages-for-today/</a> and entries on both sides).<br><br></div><div>Springer collected [all the?] images in the articles thay had published over several years. They did this without regard to the licences or ownership or authorship. They stamped this "Copyright Springer". In thousands of case this was a direct violation of copyright. I challenged this and BiomedCentral (an open access publisher then recently acquired by Springer) had to sort the mess out.<br></div><div> </div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"><div>
<div><br>
</div>
<div>US public domain to works created by federal employees works really well in areas where the US government itself posts the works online for free access. Published works that are public domain are often included in toll access packages. Not even PubMed
has free access to all the works created by its own employees.</div>
<div><br>
</div>
<div>Public domain and Creative Commons are not necessarily "free of charge". Hence if free of charge is essential to a definition of open access, neither public domain nor CC are sufficient to achieve OA.</div></div></blockquote><div><br></div><div>Material that is PD or CC BY (or CC BY-SA) can be copied without permission from the licensor and without charge. (There may be a charge for the materials involved in copying). Once someone has a copy of a PD or CC BY work they can copy it indefinitely without payment to the copyright holder. The only way that a licensor could prevent this free copying is not to make any copies available, ever.<br><br></div><div>The price of freedom is that someone should keep and advertise at least one copy of the original. If all copies happen to be lost (as may happen) then the work may effectively become "closed" .It is important, therefore, that copies are kept of all CC0/CC BY. If this is done then the work can never become closed (unless there is a retrospective change in the law or copyright, which we should fight).<br></div> <br></div><div class="gmail_quote">CC BY gives the following rights. (from <a href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</a>)<br><div id="gmail-deed-rights" dir="ltr" style="text-align:left" class="gmail-row">
<div class="gmail-col-sm-offset-2 gmail-col-sm-8"><br>You are free to:
<ul class="gmail-license-properties">
<li class="gmail-license gmail-share" rel="cc:permits">
<strong>Share</strong> — copy and redistribute the material in any medium or format
</li>
<li class="gmail-license gmail-remix" rel="cc:permits">
<strong>Adapt</strong> — remix, transform, and build upon the material
</li>
<li class="gmail-license gmail-commercial">
for any purpose, even commercially.
</li>
<li id="gmail-more-container" class="gmail-license-hidden">
<span id="gmail-devnations-container">
</span></li>
</ul>
</div>
<div id="gmail-libre" class="gmail-col-sm-2">
<a href="https://freedomdefined.org/" class="gmail-screen-only">
<br>
</a>
</div>
</div>
<div class="gmail-row">
<ul id="gmail-license-freedoms-no-icons" style="text-align:center" class="gmail-col-sm-offset-2 gmail-col-sm-8">
<li class="gmail-license">The licensor cannot revoke these freedoms as long as you follow the license terms.</li></ul><p>An added request: when referring to CC licences please specify which. I frequently see "published under a CC licence". Some CC licences are very liberal and others very restrictive. See <a href="https://creativecommons.org/licenses/">https://creativecommons.org/licenses/</a></p><p><br></p><p>P.<br></p><ul id="gmail-license-freedoms-no-icons" style="text-align:center" class="gmail-col-sm-offset-2 gmail-col-sm-8">
</ul>
</div><br><br></div><div class="gmail_quote"><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"><div>
<div><br>
</div>
<div>best,</div>
<div><br>
</div>
<div>Heather Morrison </div>
</div>
<br>______________________________<wbr>_________________<br>
GOAL mailing list<br>
<a href="mailto:GOAL@eprints.org">GOAL@eprints.org</a><br>
<a href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal" rel="noreferrer" target="_blank">http://mailman.ecs.soton.ac.<wbr>uk/mailman/listinfo/goal</a><br>
<br></blockquote></div><br><br clear="all"><br>-- <br><div class="gmail_signature"><div dir="ltr"><div>Peter Murray-Rust<br>Reader Emeritus in Molecular Informatics<br>Unilever Centre, Dept. Of Chemistry<br>University of Cambridge<br>CB2 1EW, UK<br>+44-1223-763069</div></div></div>
</div></div>